Overall, these results suggest that several MAPK and PI3K/AKT pathway components and FAK, among others, may participate in adaptive response mechanisms promoting resistance to rapamycin in HNSCC cells. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.